Lilly is studying retatrutide in several phase 3 clinical trials to evaluate its potential efficacy and safety across several indications, including obesity and overweight with 1 weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
PlexusDx supports precision-guided conversations with healthcare providers by integrating biomarker and genetic context into medication optimization
While current research focuses predominantly on hepatocytes, potential Kupffer cell modulation in NASH-related inflammation and fibrosis warrants further investigation (78)
youre investing in a holistic approach to achieving radiant health
Your stomach is emptying more slowly now
If you buy a 3-month or 6-month supply, youll also receive a free box of HerSolution pills